At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.
We recognize that patients living with immune-mediated diseases need alternatives to currently available therapies. Despite recent advances and innovations in the treatment of immune-mediated diseases, many patients continue to suffer, cycling through currently approved therapies while looking for a solution that alleviates the debilitating impact of their disease without life-limiting side effects.
Addressing the needs of these patients is why we exist. We are pioneering a precision approach that leverages insights we derive from powerful data analytics to select the right target, right molecule, right indication, right patient, and right endpoint resulting in optimized outcomes for patients. We believe that combining our insights with an integrated approach to drug development will produce the next generation of treatments to address immune dysfunction.
Incubated by Foresite Labs, Alumis is led by a team of deeply experienced professionals who are devoted to transforming the lives of patients with immune-mediated diseases by developing a pipeline of transformative therapies.
Company Details
- Employees
- 216
- Founded
- -
- Address
- 611 Gateway Blvd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.alumis.com
- Keywords
- Technician jobs.
- HQ
- South San Francisco, California
Alumis Questions
Alumis's website is https://www.alumis.com
Alumis's LinkedIn profile is https://www.linkedin.com/company/alumis-co
Alumis has
216 employees.
View email and phone details for 216
employees at Alumis.
Alumis's industry is
Biotechnology Research
Alumis's categories are Biotechnology Research
Alumis's founding year is 2021
